Serum magnesium and sudden death in European hemodialysis patients

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  De Roij Van Zuijdewijn, Camiel L M ^a,b   Grooteman, Muriel P C ^a,b   Bots, Michiel L ^c   Blankestijn, Peter J ^c   Steppan, Sonja ^d   Büchel, Janine ^d   Groenwold, Rolf H H ^c   Brandenburg, Vincent ^e   Van Den Dorpel, Marinus A ^f   Ter Wee, Piet M ^a,b   Nubé, Menso J ^a,b   Vervloet, Marc G ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d FRESENIUS MEDICAL CARE   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; PHOSPHATE;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DUTCHMAN; EUROPEAN; FEMALE; FOLLOW UP; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NON CARDIOVASCULAR MORTALITY; NORWEGIAN (PEOPLE); PHOSPHATE BLOOD LEVEL; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SENSITIVITY ANALYSIS; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL RISK; SURVIVAL TIME; ADVERSE EFFECTS; BLOOD; ETIOLOGY; EUROPE; HEMODIALYSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL ANALYSIS; TIME FACTOR;

DEATH, SUDDEN; EUROPE; HUMANS; MAGNESIUM; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84957998782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143104     Document Type: Article

References (34)

1. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006 Dec; 17(12):3510-9. PMID: 17108318
2. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999 Jul; 10(7):1606-15. PMID: 10405218
3. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999 Aug; 83(2):302-20. PMID: 10618948
4. Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in endstage renal disease. Kidney Int 1987 Sep; 32(3):388-94. PMID: 3669498
5. Kircelli F, Peter ME, Sevinc OE, Celenk FG, Yilmaz M, Steppan S, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012 Feb; 27(2):514-21. doi: 10.1093/ndt/gfr321 PMID: 21750166
6. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 2012; 35(1):31-9. doi: 10.1159/000334742 PMID: 22179063
7. Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R. Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys 2007 Feb 1; 458(1):73-89. PMID: 17123458
8. Maier JA. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 2003 Feb; 24(1-3):137-46. PMID: 12537993
9. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998 Sep; 136(3):480-90. PMID: 9736141
10. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2010 Sep; 160(3):464-70. doi: 10.1016/j.ahj.2010.06.012 PMID: 20826254
11. Hruby A, O'Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. JACC Cardiovasc Imaging 2014 Jan; 7(1):59-69. doi: 10.1016/j.jcmg.2013.10.006 PMID: 24290571
12. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013 Jul; 98(1):160-73. doi: 10.3945/ajcn.112.053132 PMID: 23719551
13. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007 Dec; 20(4):237-44. PMID: 18271493
14. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 2014 Jan; 85(1):174-81. doi: 10.1038/ki.2013.327 PMID: 23986148
15. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Iseki K, et al. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study. PLoS One 2014; 9(12):e116273. doi: 10.1371/journal.pone.0116273 PMID: 25545498
16. Lopes AA, Bragg-Gresham JL, Elder SJ, Ginsberg N, Goodkin DA, Pifer T, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Nutr 2010 Jul; 20(4):224-34. doi: 10.1053/j.jrn.2009.10.002 PMID: 20060319
17. Satayathum S, Pisoni RL, McCullough KP, Merion RM, Wikstrom B, Levin N, et al. Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2005 Jul; 68(1):330-7. PMID: 15954924
18. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 2003 Sep; 17(9):623-30. PMID: 13679952
19. Lacson E Jr, Wang W, Ma L, Passlick-Deetjen J. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis 2015 Jul 16. doi: 10.1053/j.ajkd.2015. 06.014 PMID: 26190226
20. Li L, Streja E, Rhee CM, Mehrotra R, Soohoo M, Brunelli SM, et al. Hypomagnesemia and Mortality in Incident Hemodialysis Patients. Am J Kidney Dis 2015 Jul 13. doi: 10.1053/j.ajkd.2015.05.024 PMID: 26184377
21. Joao Matias P, Azevedo A, Laranjinha I, Navarro D, Mendes M, Ferreira C, et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif 2014; 38(3-4):244-52. doi: 10.1159/000366124 PMID: 25573320
22. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012 Jun; 23(6):1087-96. doi: 10.1681/ASN.2011121140 PMID: 22539829
23. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients-the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 2005 May 20; 6(1):8. PMID: 15907201
24. Naimi AI, Moodie EE, Auger N, Kaufman JS. Constructing inverse probability weights for continuous exposures: a comparison of methods. Epidemiology 2014 Mar; 25(2):292-9. doi: 10.1097/EDE. 0000000000000053 PMID: 24487212
25. Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007 Nov; 2(6):1241-8. PMID: 17928470
26. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004 Jun; 19 (6):1480-8. PMID: 15034154
27. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in endstage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003 Sep; 18(9):1731-40. PMID: 12937218
28. Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphateinduced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 2013 Apr; 28(4):869-78. doi: 10.1093/ndt/gfs520 PMID: 23229924
29. Montes de OA, Guerrero F, Martinez-Moreno JM, Madueno JA, Herencia C, Peralta A, et al. Magnesium inhibits Wnt/beta-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One 2014; 9(2):e89525. doi: 10.1371/journal.pone.0089525 PMID: 24586847
30. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012; 36(3):228-37. PMID: 22948239
31. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000 Nov 7; 102 (19):2353-8. PMID: 11067788
32. Pearson PJ, Evora PR, Seccombe JF, Schaff HV. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thorac Surg 1998 Apr; 65(4):967-72. PMID: 9564911
33. de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010 Nov; 25(11):3707-17. doi: 10.1093/ndt/gfq292 PMID: 20530499
34. Covic A, Passlick-Deetjen J, Kroczak M, Buschges-Seraphin B, Ghenu A, Ponce P, et al. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transplant 2013 Sep; 28(9):2383-92. doi: 10.1093/ndt/gft203 PMID: 23787550